These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-004937-13 multicentee randomized controlled study of azathioprine versus iterferon beta in relapsing remitting multiple sclerosis not-yet-due
Ongoing 2008-005028-10 Methadone dose adjustments, plasma R-methadone levels and therapeutic outcome of opioid addiction not-yet-due
Ongoing 2010-022835-13 The Effects of Nicotine withdrawal on Panic-like Response to Breath Holding: A Placebo-Controlled, Double-Blind, Cross-Over Patch Study not-yet-due
Not reported 2012-002253-30 A phase 2 study of Ruxolitinib in patients with splanchnic vein thrombosis associated with myeloproliferative neoplasm Studio di fase II del Ruxolitinib in pazienti con Trombosi delle Vene Splancni... 2023-07-06 due-trials
Ongoing 2013-001890-26 Recombinant human parathyroid hormone [rh PTH(1-34): Teriparatide] as therapy for refractory hypoparathyroidism Ormone paratiroideo ricombinante umano [rh PTH(1-34): Teriparatide] per il trattament... not-yet-due
Ongoing 2014-004134-26 A MULTICENTER, PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PILOT STUDY ON THE BENEFIT/COST/SAFETY PROFILE OF SOFOSBUVIR FOR SYMPTOMATIC MIXED CRYOGLOBULINEMIA Studio pilota multicentrico, prospettico, a s... not-yet-due
Ongoing 2014-004422-17 Double-blinded placebo-controlled study on men with lower urinary tract symptoms secondary to prostatic hyperplasia (LUTS-BPH) to assess changes in pressure flow study (PFS) and in molecular profile o... not-yet-due
Ongoing 2015-000914-23 Cardiac toxicity prevention in non-metastatic breast cancer patients treated with anthracycline-based chemotherapy: a randomized, placebo controlled, phase 3 trial - SAFE trial. MONITORAGGIO E PREV... not-yet-due
Ongoing 2016-005284-13 A 2 arm, phase II controlled randomized trial comparing efficacy and safety of abiraterone and abiraterone associated with Ablative Radiation Therapy in patients with Oligometastatic castration resist... not-yet-due
Other 2020-000428-21 ExclUsive endocRine therapy Or Partial breast irradiation for women aged =70 years with luminal A-like early stage breast cancer (EUROPA): a randomized phase 3 non-inferiority trial. Terapia endocr... not-yet-due
Ongoing 2020-001165-36 A Phase 2, Monocentric, Pilot Study to evaluate safety and efficacy of CC 486 (Oral Azacitidine) Plus Best Supportive Care as maintenance of response to sc azacitidine in IPSS higher risk elderly MDS ... not-yet-due
Completed, report not yet due 2021-001826-23 A prospective, non controlled, phase 2 pilot study to assess the safety and efficacy of a new topical formulation of clobetasol 0.05% for mucosal use in patients with mucous membrane pemphigoid Stu... 2024-09-17 not-yet-due